194 related articles for article (PubMed ID: 21752881)
1. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
[TBL] [Abstract][Full Text] [Related]
2. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract][Full Text] [Related]
3. FOXO3a: a novel player in thyroid carcinogenesis?
Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
Nozhat Z; Hedayati M
Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
[TBL] [Abstract][Full Text] [Related]
5. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
6. Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway.
Takeuchi A; Koga K; Satake E; Makabe T; Taguchi A; Miyashita M; Takamura M; Harada M; Hirata T; Hirota Y; Yoshino O; Wada-Hiraike O; Fujii T; Osuga Y
J Clin Endocrinol Metab; 2019 Nov; 104(11):5547-5554. PubMed ID: 31219551
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
8. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.
Zhou H; Liu W; Su Y; Wei Z; Liu J; Kolluri SK; Wu H; Cao Y; Chen J; Wu Y; Yan T; Cao X; Gao W; Molotkov A; Jiang F; Li WG; Lin B; Zhang HP; Yu J; Luo SP; Zeng JZ; Duester G; Huang PQ; Zhang XK
Cancer Cell; 2010 Jun; 17(6):560-73. PubMed ID: 20541701
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells.
Chen Q; Ganapathy S; Singh KP; Shankar S; Srivastava RK
PLoS One; 2010 Dec; 5(12):e15288. PubMed ID: 21179458
[TBL] [Abstract][Full Text] [Related]
10. Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa.
Ausserlechner MJ; Salvador C; Deutschmann A; Bodner M; Viola G; Bortolozzi R; Basso G; Hagenbuchner J; Obexer P
Oncotarget; 2013 Jul; 4(7):995-1007. PubMed ID: 23828551
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
13. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
14. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.
Stahl M; Dijkers PF; Kops GJ; Lens SM; Coffer PJ; Burgering BM; Medema RH
J Immunol; 2002 May; 168(10):5024-31. PubMed ID: 11994454
[TBL] [Abstract][Full Text] [Related]
15. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand.
Engström M; Karlsson R; Jönsson JI
Exp Hematol; 2003 Apr; 31(4):316-23. PubMed ID: 12691919
[TBL] [Abstract][Full Text] [Related]
18. The role of FOXO3 in DNA damage response in thyrocytes.
Klagge A; Weidinger C; Krause K; Jessnitzer B; Gutknecht M; Fuhrer D
Endocr Relat Cancer; 2011 Oct; 18(5):555-64. PubMed ID: 21712344
[TBL] [Abstract][Full Text] [Related]
19. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
20. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
